SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McSweeney Erin

(Last)

(First)

(Middle)

C/O UNITEDHEALTH GROUP

9900 BREN ROAD EAST

(Street)

MINNETONKA

55343

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/13/2022

3. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP Chief People Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	9,501.985	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Non-Qualified Stock Options	⁽¹⁾	02/26/2029	Common Stock	10,689	$262.98	D
Non-Qualified Stock Options	⁽²⁾	02/13/2030	Common Stock	15,248	$302.2	D
Non-Qualified Stock Options	⁽³⁾	02/22/2031	Common Stock	14,282	$327.64	D
Non-Qualified Stock Options	⁽⁴⁾	06/07/2031	Common Stock	5,680	$400.25	D
Non-Qualified Stock Options	⁽⁵⁾	02/14/2032	Common Stock	8,673	$474.4	D

Explanation of Responses:

1. The stock options became exercisable as to 5,344 shares on February 26, 2022, and will become exercisable as to 5,345 shares on February 26, 2023.

2. The stock options became exercisable as to 1,000 shares on February 13, 2021, 4,749 shares on February 13, 2022, and will become exercisable as to 4,749 shares on February 13, 2023 and 4,750 shares on February 13, 2024.

3. The stock options became exercisable as to 3,570 shares on February 22, 2022, and will become exercisable as to 3,571 shares on February 22, 2023, 3,570 shares on February 22, 2024 and 3,571 shares on February 22, 2025.

4. The stock options vest at a rate of 25% annually on June 7 from the years 2022 through 2025.

5. The stock options vest at a rate of 25% annually on February 14 from the years 2023 through 2026.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Erin L. McSweeney	04/22/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.